We Develop Proprietary Peptide Drugs for Outpatient Therapy

Our programs include: 

• Refractory Ascites 
• Lung Diseases:
  – Acute Respiratory Distress Syndrome (ARDS)
  – Pulmonary Fibrosis (PF)
  – Pulmonary Hypertension (PH)
• Cancer Immunotherapy 
• Refractory Hypertension 

AsahiKasei, PeptiDream, and Shionogi are our partners/investors.

We welcome additional partners for in-/out-licensing/co-development and go-to-market.

Please contact us:

PharmaIN Corporation
11812 N Creek Parkway N, Ste. 101
Bothell, WA 98011 USA